Bullfrog AI Holdings, Inc. (BFRG)
NASDAQ: BFRG · Real-Time Price · USD
2.420
-0.020 (-0.82%)
Oct 29, 2024, 4:00 PM EDT - Market closed

Company Description

Bullfrog AI Holdings, Inc., through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States.

The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.

It also has licensing agreements with George Washington University for rights to use siRNA targeting Beta2-spectrin in the treatment of human diseases, including hepatocellular carcinoma, obesity, non-alcoholic fatty liver disease, and non-alcoholic steatohepatitis; and Johns Hopkins University for the use of a formulation of Mebendazole for the treatment of glioblastoma, and human cancer or neoplastic disease.

The company was founded in 2017 and is based in Gaithersburg, Maryland.

Bullfrog AI Holdings, Inc.
Bullfrog AI Holdings logo
Country United States
Founded 2017
IPO Date Feb 14, 2023
Industry Health Information Services
Sector Healthcare
Employees 11
CEO Vininder Singh

Contact Details

Address:
325 Ellington Boulevard, Unit 317
Gaithersburg, Maryland 20878
United States
Phone 240 658 6710
Website bullfrogai.com

Stock Details

Ticker Symbol BFRG
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $6.50
CIK Code 0001829247
ISIN Number US12021E1091
Employer ID 84-4786155
SIC Code 2834

Key Executives

Name Position
Vininder Singh Founder, Chairman and Chief Executive Officer
Dane R. Saglio Chief Financial Officer
J. T. Koffenberger Chief Information Officer
Hon. Thomas W. Chittenden X, DPHIL, Ph.D. Chief Scientific Officer
Dr. Cetin Savkli Ph.D. Chief AI Advisor and Member of Advisory Board
Dr. David P. Recker FACP, FACR, M.D. Chief Medical Officer

Latest SEC Filings

Date Type Title
Oct 21, 2024 8-K Current Report
Oct 21, 2024 424B5 Filing
Oct 15, 2024 8-K Current Report
Oct 9, 2024 8-K Current Report
Oct 3, 2024 144 Filing
Sep 25, 2024 8-K Current Report
Aug 21, 2024 EFFECT Notice of Effectiveness
Aug 15, 2024 S-3/A [Amend] Registration statement under Securities Act of 1933
Aug 13, 2024 UPLOAD Filing
Aug 8, 2024 DEF 14A Other definitive proxy statements